Bookdose Path vs PRIME VizApp
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Bookdose Path
This platform provides easy access to licensed e-books through collaborations with leading Thai publishers. It's designed for organizations to facilitate access to copyrighted digital content.
- Access licensed e-books
- Collaborations with leading publishers
- Facilitates organizational access
- Professional e-book reader
Read full descriptionHide full description
Bookdose Path คือ E-book Reader Platform ที่ Bookdose จับมือร่วมกับสำนักพิมพ์ชั้นนำของประเทศไทยมากมาย เพื่ออำนวยความสะดวกให้กับทุกหน่วยงาน/องค์กรต่างๆ ให้สามารถเข้าถึงอีบุ๊คลิขสิทธิ์ได้อย่างง่ายดาย Bookdose Path is a professional E-book Reader Platform that Bookdose company collaborates with leading publishers in Thailand. In order to facilitate all organisations to access licensed e-books easier.
PRIME VizApp
Read full descriptionHide full description
PRIME VizApp is the educational companion to the Ultherapy PRIME training programme. It brings the course reference material into one searchable, offline-ready app for trained professionals.
Screenshots
Verdict
The clearest difference is update cadence: PRIME VizApp at every 3 days against Bookdose Path's every 5 weeks. Bookdose Path's advantage is iOS requirement (14.0 vs 16.4). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Bookdose Path ships an update every 5 weeks, PRIME VizApp every 3 days. The most recent releases landed on October 16, 2026 and October 7, 2026 respectively.
| Parameter | Bookdose Path | PRIME VizApp |
|---|---|---|
| Price | Free | Free |
| Positive reviews | 75.0% of reviews | — |
| Update frequency | Every 5 weeks | Every 3 days — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 14.0 — better | 16.4 |
| Further details — not scored | ||
| Size | 83 MB | 155 MB |
| Age rating | 12+ | 17+ |
| Developer | BOOKDOSE COMPANY LIMITED | Merz Pharma GmbH & Co. KGaA |
In-app purchases
Bookdose Path
No in-app purchases
PRIME VizApp
No in-app purchases
